beta-lapachone has been researched along with Cardiomyopathies in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, MH | 1 |
| Tran, NK | 1 |
| Kwak, TH | 1 |
| Park, BK | 1 |
| Lee, CS | 1 |
| Park, TS | 1 |
| Lee, YH | 1 |
| Park, WJ | 1 |
| Yang, DK | 1 |
1 other study available for beta-lapachone and Cardiomyopathies
| Article | Year |
|---|---|
β-Lapachone ameliorates lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.
Topics: Acyl Coenzyme A; Acyltransferases; AMP-Activated Protein Kinases; Animals; Cardiomyopathies; Fibrosi | 2014 |